Phospholipase A2 Inhibitor Impacts on Inhaled Allergen Challenge In Subjects With Asthma

Phospholipase A2 Inhibitor
In asthma, the secretory phospholipases A2 (sPLA2) have been implicated in the release of arachidonic acid from cellular membranes, the generation of lysophospholipids, the sPLA2-mediated activation of cellular PLA2 (cPLA2) with increased Leukotriene Receptor Antagonist synthesis, and the breakdown of surfactant. In this double-blind, placebo-controlled, random-order crossover study, a potent inhibitor of sPLA2, LY333013, was assessed. (more…)

Atopic Dermatitis Risk Factors in Children at 3.5 Years Of Age

Atopic Dermatitis Children
The prevalence of atopic dermatitis is increasing in Western societies. The hygiene hypothesis proposes that this is due to reduced exposure to environmental allergens and infections during early life. The authors examined factors associated with a diagnosis of atopic dermatitis at 3.5 years of age, especially those factors implicated by the hygiene hypothesis. The Auckland Birthweight Collaborative study is a case–control study of risk factors for small-for-gestational-age babies. Cases were born at term with birth weight at or below the 10th centile; controls were appropriate for gestational age, with birth weight above the 10th centile. (more…)